On November 7, TD Cowen raised the price target on Arm to $165 from $150 and kept a Buy rating on the shares. The advisory ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a price target of $73.00. The company’s shares closed last ...

Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...

Jeff Solomon, TD Cowen president, joins CNBC's 'Money Movers' to discuss how a Trump administration will impact the markets ...

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...

On Friday, JetBlue Airways Corporation (JBLU) stock saw a modest uptick, ending the day at $6.34 which represents a slight increase of $0.29 or 4.79% from the prior close of $6.05. The stock opened at ...

TD Cowen raised the firm’s price target on Progressive (PGR) to $237 from $197 and keeps a Hold rating on the shares. The firm updated ...

On Friday, Array Technologies Inc (ARRY) stock saw a decline, ending the day at $6.04 which represents a decrease of $-0.16 or -2.58% from the prior close of $6.2. The stock opened at $6.21 and ...

TD Cowen on potential opportunities in Canadian equities. The potential impact of Canadian mortgage resets in 2025. Why demographic uncertainty could be a major challenge for the Canadian economy.

Logistics professionals navigating their path forward face challenging market conditions, an evolving regulatory environment, a rapidly changing technology landscape, and an increasingly competitive ...

TD Cowen upgraded Universal Health Services stock from Hold to Buy, catapulting its price target from $220 to $283 per share.Market Domination anchors Julie Hyman and Josh Lipton discuss TD Cowen ...

Investing.com -- TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in European markets that are expected to delay the company ...